BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  ImmusanT Data Shows Up-Dosing Substantially Increases Nexvax2 Dose Levels That Are Safe and Tolerable, Further Supports Phase II Studies

  This study demonstrates that gradually increasing the dose from a low, well-tolerated starting dose enables Nexvax2 to be safe and tolerable without dose-limiting adverse events at a level of 900 μg,.

  November 28, 2017

   · 

  5 min read
• Business

  Applied Photophysics Expands Management Team and Strengthens Sales and Application Support

  The Company has also expanded its sales and scientific support teams across the US, UK and Germany with the addition of four Sales Managers and two more Application Scientists

  November 28, 2017

   · 

  3 min read
• Business

  Cosmos Holdings Announces Third Quarter 2017 Results

  Cosmos Holdings announced financial results for the quarter ended September 30, 2017.

  November 28, 2017

   · 

  2 min read
• Drug Development

  PhaseRx Receives Positive Opinion for Orphan Drug Designation for PRX-ASL From EMA

  PhaseRx today announced that the EMA’s Committee for Orphan Medicinal Products has issued a positive opinion recommending orphan medicinal product designation for PRX-ASL, for the treatment of ASLD, PhaseRx’s second drug candidate to treat a urea cycle disorder.

  November 28, 2017

   · 

  5 min read
• Biotech Bay

  Veracyte Announces Publication of Data Confirming Analytical Validity of Envisia Genomic Classifier for Use in IPF Diagnosis

  The findings add to the growing body of evidence, including previously reported clinical validity and clinical utility data, supporting the use of the Envisia classifier to enable diagnosis of IPF, without the need for invasive, risky and costly surgical procedures.

  November 28, 2017

   · 

  5 min read
• Business

  Cannabics Pharmaceuticals Received a New Research License for Characterization of Anti-Tumor Activity of Cannabinoids

  The new license will enable the company to continue our vision of developing an ecosystem for creation of diagnostic tools and bringing to the market diagnostic services for cancer patients who are medicated with cannabis.

  November 28, 2017

   · 

  2 min read
• 

  Policy

  Repro-Med Clears 2016 FDA Warning Letter, Shakes Up C-Suite

  Repro-Med said the closure of the warning letter stemmed from its successful bid for 510(k) clearance for its Integrated Catch-Up Freedom Syringe Driver System, granted in September.

  November 28, 2017

   · 

  3 min read
• Business

  Zeriscope Awarded Army Contract to Support Treatment Research in Traumatic Brain Injury

  Zeriscope’s real-time streaming telemedicine platform is being used along with its integrated wearable sensor kit to monitor heart rate variability (HRV), a biomarker associated with the ability to regulate the autonomic nervous system, attentiveness and emotional responses.

  November 28, 2017

   · 

  2 min read
• Business

  Lexogen and Partek Deliver QuantSeq Analysis Solution

  This pipeline enables Lexogen customers to import raw sequencing files directly into Partek Flow to automate analysis and removes the barrier for those without an advanced bioinformatics background.

  November 28, 2017

   · 

  3 min read
• Genetown

  Voluntis to Integrate Insulia With Onduo Virtual Diabetes Clinic

  The integrated solution will launch in pilot programs with US providers and payers in early 2018.

  November 28, 2017

   · 

  3 min read